These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Metabolic studies on mycobacteria. IV. Assay of isocitrate lyase and malate synthase activity in M. leprae. Bharadwaj VP; Katoch VM; Sharma VD; Kannan KB; Datta AK; Shivannavar CT Indian J Lepr; 1987; 59(2):158-62. PubMed ID: 3116105 [TBL] [Abstract][Full Text] [Related]
24. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. Gould TA; van de Langemheen H; Muñoz-Elías EJ; McKinney JD; Sacchettini JC Mol Microbiol; 2006 Aug; 61(4):940-7. PubMed ID: 16879647 [TBL] [Abstract][Full Text] [Related]
25. Targeting isocitrate lyase for the treatment of latent tuberculosis. Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043 [TBL] [Abstract][Full Text] [Related]
26. Mechanism-based inactivator of isocitrate lyases 1 and 2 from Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637 [TBL] [Abstract][Full Text] [Related]
27. Biochemical properties and crystal structure of isocitrate lyase from Bacillus cereus ATCC 14579. Lee SH; Ki D; Kim S; Kim IK; Kim KJ Biochem Biophys Res Commun; 2020 Dec; 533(4):1177-1183. PubMed ID: 33041004 [TBL] [Abstract][Full Text] [Related]
28. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database. Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711 [TBL] [Abstract][Full Text] [Related]
30. Cysteine is the general base that serves in catalysis by isocitrate lyase and in mechanism-based inhibition by 3-nitropropionate. Moynihan MM; Murkin AS Biochemistry; 2014 Jan; 53(1):178-87. PubMed ID: 24354272 [TBL] [Abstract][Full Text] [Related]
31. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof]. Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772 [TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages]. Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266 [TBL] [Abstract][Full Text] [Related]
33. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial antibodies by phage display: Identification of antibody-based inhibitor against mycobacterium tuberculosis isocitrate lyase. Ch'ng ACW; Schepergerdes L; Choong YS; Hust M; Lim TS Mol Immunol; 2022 Oct; 150():47-57. PubMed ID: 35987135 [TBL] [Abstract][Full Text] [Related]
35. Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening. Ji L; Long Q; Yang D; Xie J Int J Biol Sci; 2011 Apr; 7(3):376-82. PubMed ID: 21494431 [TBL] [Abstract][Full Text] [Related]
36. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nandakumar M; Nathan C; Rhee KY Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671 [TBL] [Abstract][Full Text] [Related]
37. Rv1915 and Rv1916 from Mycobacterium tuberculosis H37Rv form in vitro protein-protein complex. Antil M; Gupta V Biochim Biophys Acta Gen Subj; 2022 Jun; 1866(6):130130. PubMed ID: 35307510 [TBL] [Abstract][Full Text] [Related]
38. Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. Jayamani J; Shanmugam G Eur J Med Chem; 2014 Oct; 85():352-8. PubMed ID: 25105923 [TBL] [Abstract][Full Text] [Related]
39. [Molecular cloning, expression, purification and properties of isocitrate lyase gene from Mycobacterium tuberculosis H37Rv]. Hao F; Pei XY; Zhang XL; Zhang SB; Lai XH; Wang HH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):845-8. PubMed ID: 16409788 [TBL] [Abstract][Full Text] [Related]
40. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis. Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]